According to the research report titled ‘Europe Fumed Silica Market Size Application, By Product, Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027’, available with Market Study Report, Europe fumed silica market is expected to accumulate USD 437 million over 2021-2027.
 

Consumer inclination towards high-end beauty and personal care products as well as surging product demand from pharmaceutical sector for smooth production procedure are catalyzing the growth of Europe fumed silica industry.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3855687/
 

For the unversed, fumed silica is used as an anti-caking and thickening agent in powders, as well as light diffusing property and abrasive make it ideal for cosmetics and toothpastes. It also serves as a desiccant in different formulations.
 

Based on product terrain, the marketspace is bifurcated into hydrophobic and hydrophilic. Among these, hydrophilic segment accounted for 64% market share in 2020 and is expected to grow further, owing to its cost effectiveness, adoption in non-polar resin system, and superior insulation properties at high temperature. Hydrophilic fumed silica can be easily dispersed in water and are used in products with no shelf-life concern. It is largely adopted in food & beverage and industrial sectors for thickening silicone and as a glidant.
 

In terms of application gamut, Europe fumed silica industry is classified into pharmaceutical, beauty & personal care, UPR (unsaturated polymer resin), food & beverage, silicone elastomer, adhesives & sealants, paints, coatings & ink, and others.
 

As per the report, UPR segment is poised to generate revenues for the market, owing to usage of  fumed silica in production of UPR and rising demand for resins. Whereas, expanding construction sector will encourage product demand from paint, coatings & inks applications segment.
 

Europe fumed silica industry share from pharmaceutical, beauty, and personal care segment is expected to be 27% by the year 2027, owing to widespread usage of product as disintegrant, binder, glidant, sorbent as well as filler in producing capsules, powders, and tablets, coupled with its ability to function as pharmaceutical excipient that enhances drug development procedure in a cost-effective manner.
 

Lastly, the competitive landscape of the industry is defined by companies such as Hubei Xingfa Chemicals group Co. Ltd., Kemitura A/S, Evonik Industries AG, Cabot Corporation, Tokuyama Corporation, Reade International Corp., Lawrence Industries Inc., Flexicon Corporation, Wacker Chemie AG, and Orisil Ltd.